RESTON, Va., Sept. 17, 2018 /PRNewswire-PRWeb/ -- A new White Paper from Clinical Care Options (CCO), a global leader
The results of CCO's survey of 227 US clinicians demonstrate profound gaps in clinicians' general knowledge of the changes introduced by Medicare Access and CHIP Reauthorization Act (MACRA). In particular, 60% were unaware that participating in appropriate CME activities not only can help them improve the quality of care they provide, but also can help them gain points toward the Improvement Activity component of their overall performance score, which in turn determines the rate of Medicare reimbursement payments that they will receive.
The ability to report participation in appropriate CME activities to meet the requirement for engagement in Improvement Activities within the Merit-Based Incentive Payments System (MIPS) is new in 2018. There is a clear opportunity for participation in such CME activities, already a trusted resource used by hundreds of thousands of clinicians, to play a significant role in enabling clinicians to demonstrate their commitment to enhancing patient outcomes and the quality of care.
"These data indicate that a great deal of work needs to be done to improve clinicians' awareness that appropriate CME activities can help them meet the MIPS requirements for participating in Improvement Activities," said Robin Murray, President, CCO. "At the same time, it is reassuring to see that large proportions of respondents were interested in participating in activities that carried MIPS Improvement Activity designation as well as offering CME credits or maintenance of certification points, suggesting that awareness is the key barrier to uptake."
The White Paper can be found here: https://www.clinicaloptions.com/publications/2018/9_2018_mips_whitepaper
About Clinical Care Options Clinical Care Options, LLC, is a global leader in the development of innovative educational programs and technology platforms. CCO's team has been a pioneer in the creation of continuing education and decision support resources for healthcare professionals both in the United States and around the world for more than 2 decades. For more information, visit clinicaloptions.com
Contact: Tradd Sanderson | Director of Marketing Clinical Care Options
SOURCE Clinical Care Options
Subscribe to our Free Newsletters!
FDA approved elapegademase-lvlr injection for intramuscular use is used as an enzyme replacement ...
Armpit lumps and raised bumps in the armpits caused by infection, cysts and other types of ...
Bad eating habits will affect your health as well as your skin and make you look older than your ...View All